Research.Patient.info
Age-related Macular Degeneration (AMD) research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
This study is looking into new treatments, pozelimab and cemdisiran, for Geographic Atrophy (GA), an advanced form of Age-related Macular Degeneration (AMD). It compares these new drugs, alone or together, against a placebo to see if they can slow down vision loss.
United States · Australia · Austria - recruitingPHASE2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
This study is testing a new eye drop and an injection for a common cause of vision loss called Geographic Atrophy (GA), linked to Age-related Macular Degeneration (AMD). It aims to see how well these treatments work and if they are safe for people aged 55 and over.
United States · Austria · Canada